Pressure BioSciences Statistics
Total Valuation
PBIO has a market cap or net worth of $5.51 million. The enterprise value is $24.02 million.
Market Cap | 5.51M |
Enterprise Value | 24.02M |
Important Dates
Earnings Date | n/a |
Ex-Dividend Date | n/a |
Share Statistics
PBIO has 25.74 million shares outstanding. The number of shares has increased by 95.09% in one year.
Shares Outstanding | 25.74M |
Shares Change (YoY) | +95.09% |
Shares Change (QoQ) | +11.53% |
Owned by Insiders (%) | 1.14% |
Owned by Institutions (%) | 0.03% |
Float | 21.57M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 2.42 |
Forward PS | n/a |
PB Ratio | n/a |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 10.57 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.03
Current Ratio | 0.03 |
Quick Ratio | 0.01 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | 1.84 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -399,259.13% |
Return on Capital (ROIC) | n/a |
Revenue Per Employee | $142,037 |
Profits Per Employee | -$399.79M |
Employee Count | 16 |
Asset Turnover | 1.20 |
Inventory Turnover | 2.73 |
Taxes
In the past 12 months, PBIO has paid $6.38 billion in taxes.
Income Tax | 6.38B |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -75.63% in the last 52 weeks. The beta is -0.07, so PBIO's price volatility has been lower than the market average.
Beta (1Y) | -0.07 |
52-Week Price Change | -75.63% |
50-Day Moving Average | 0.21 |
200-Day Moving Average | 0.34 |
Relative Strength Index (RSI) | 49.25 |
Average Volume (30 Days) | 92,398 |
Short Selling Information
The latest short interest is 6,336, so 0.02% of the outstanding shares have been sold short.
Short Interest | 6,336 |
Short Previous Month | 107 |
Short % of Shares Out | 0.02% |
Short % of Float | 0.03% |
Short Ratio (days to cover) | 3.00 |
Income Statement
In the last 12 months, PBIO had revenue of $2.27 million and -$6.40 billion in losses. Loss per share was -$403.71.
Revenue | 2.27M |
Gross Profit | -256,404 |
Operating Income | -7.97M |
Pretax Income | -24.50M |
Net Income | -6.40B |
EBITDA | -7.85M |
EBIT | -7.99M |
Loss Per Share | -$403.71 |
Balance Sheet
The company has $5,263 in cash and $18.52 million in debt, giving a net cash position of -$18.52 million or -$0.72 per share.
Cash & Cash Equivalents | 5,263 |
Total Debt | 18.52M |
Net Cash | -18.52M |
Net Cash Per Share | -$0.72 |
Equity / Book Value | -28.60M |
Book Value Per Share | -1.11 |
Working Capital | -28.94M |
Cash Flow
In the last 12 months, operating cash flow was -$3.48 million and capital expenditures -$7,496, giving a free cash flow of -$3.49 million.
Operating Cash Flow | -3.48M |
Capital Expenditures | -7,496 |
Free Cash Flow | -3.49M |
FCF Per Share | -$0.16 |
Margins
Gross margin is -11.28%, with operating and profit margins of -350.79% and -281,468.17%.
Gross Margin | -11.28% |
Operating Margin | -350.79% |
Pretax Margin | -1,078.11% |
Profit Margin | -281,468.17% |
EBITDA Margin | -345.47% |
EBIT Margin | -351.46% |
FCF Margin | -153.49% |
Dividends & Yields
PBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -95.09% |
Shareholder Yield | -95.09% |
Earnings Yield | -116,179.27% |
FCF Yield | -63.35% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 5, 2017. It was a reverse split with a ratio of 1:30.
Last Split Date | Jun 5, 2017 |
Split Type | Reverse |
Split Ratio | 1:30 |
Scores
PBIO has an Altman Z-Score of -175.1 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -175.1 |
Piotroski F-Score | 3 |